ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc. (ORIC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ORIC · as of Mar 31, 2025
Ownership Breakdown
144
Institutional Holders
▲ 8 vs Q4
$442.00M
Total Inst. Value
▼ $169.68M vs Q4
103.52M
Shares Outstanding
freeFloat 47.05%
79.21M
13F Shares Held
▲ 3.42M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ORIC largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP pharmaceutical preparations | 6.57M | 9.25% | 9.25% | $36.68B | May 15, 2025 | ▲ 2.14M |
BLACKROCK, INC. pharmaceutical preparations | 5.44M | 7.65% | 7.65% | $30.33B | May 2, 2025 | ▲ 322.1K |
PFIZER INC pharmaceutical preparations | 5.38M | 7.57% | 7.57% | $30.00B | May 13, 2025 | — held |
NEXTECH INVEST, LTD. pharmaceutical preparations | 5.29M | 7.44% | 7.44% | $29.49B | May 15, 2025 | NEW |
ALKEON CAPITAL MANAGEMENT LLC pharmaceutical preparations | 4.00M | 5.64% | 5.64% | $22.34B | May 15, 2025 | ▲ 100.0K |
COLUMN GROUP LLC pharmaceutical preparations | 3.54M | 4.98% | 4.98% | $19.76B | May 14, 2025 | — held |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 3.42M | 4.81% | 4.81% | $19.07B | May 15, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 3.22M | 4.53% | 4.53% | $17.94B | May 9, 2025 | ▲ 12.1K |
VR ADVISER, LLC pharmaceutical preparations | 3.18M | 4.48% | 4.48% | $17.76B | May 15, 2025 | ▼ 1.21M |
FMR LLC pharmaceutical preparations | 2.48M | 3.49% | 3.49% | $13.84B | May 12, 2025 | ▲ 12.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
22
Increased
+7.87M shares8
New Positions
first time holders13
Decreased
−5.09M shares0
Sold Out
fully exitedNet shares change (top 50)
+2.78M
+7.87M / −5.09M
Net new holders
+17
8 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ORIC insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
12
Buy transactions
4
Sell transactions
3.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Piscitelli Dominic Chief Financial Officer | Feb 24, 2026 | Sale | 52,000 | $13.51 | $702.7K | 68.1K | Form 4 ↗ |
Heyman Richard A. director | Jan 16, 2026 | Sale | 3,200 | $12.00 | $38.4K | 213.1K | Form 4 ↗ |
Heyman Richard A. director | Jan 16, 2026 | Sale | 3,500 | $12.00 | $42.0K | 41.8K | Form 4 ↗ |
You Angie director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Kunkel Lori Anne director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Hoerter Steven L. director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Heyman Richard A. director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Dier Mardi director | Jan 2, 2026 | Award | 40,000 | $8.17 | $326.8K | 40.0K | Form 4 ↗ |
Piscitelli Dominic Chief Financial Officer | Jan 2, 2026 | Award | 206,500 | $8.17 | $1.69M | 206.5K | Form 4 ↗ |
Multani Pratik S Chief Medical Officer | Jan 2, 2026 | Award | 214,000 | $8.17 | $1.75M | 214.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ORIC Pharmaceuticals, Inc. (ORIC) is primarily owned by institutional investors, who hold approximately 76.5% of total shares outstanding. Company insiders own approximately 52.95%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of ORIC Pharmaceuticals, Inc. is VIKING GLOBAL INVESTORS LP, holding approximately 6.57 million shares — equal to 9.25% of outstanding shares — as of March 31, 2025.
A total of 144 institutional investors currently hold ORIC stock, with a combined institutional value of approximately $442,003,981 as of the most recent 13F filing period.
Frequently asked questions
ORIC ownershipORIC Pharmaceuticals, Inc. (ORIC) is primarily owned by institutional investors, who hold approximately 76.5% of shares. The largest shareholder is VIKING GLOBAL INVESTORS LP with a 9.25% stake. Company insiders hold 52.95%. Data sourced from SEC Form 13F as of March 31, 2025.